KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accounts Payables: 2009-2024

Historic Accounts Payables for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $89.6 million.

  • Exact Sciences' Accounts Payables rose 32.46% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.4 million, marking a year-over-year increase of 32.46%. This contributed to the annual value of $89.6 million for FY2024, which is 13.65% up from last year.
  • According to the latest figures from FY2024, Exact Sciences' Accounts Payables is $89.6 million, which was up 13.65% from $78.8 million recorded in FY2023.
  • Over the past 5 years, Exact Sciences' Accounts Payables peaked at $89.6 million during FY2024, and registered a low of $35.7 million during FY2020.
  • Its 3-year average for Accounts Payables is $81.1 million, with a median of $78.8 million in 2023.
  • Data for Exact Sciences' Accounts Payables shows a peak YoY spiked of 89.95% (in 2021) over the last 5 years.
  • Exact Sciences' Accounts Payables (Yearly) stood at $35.7 million in 2020, then spiked by 89.95% to $67.8 million in 2021, then increased by 10.45% to $74.9 million in 2022, then increased by 5.21% to $78.8 million in 2023, then increased by 13.65% to $89.6 million in 2024.